SG47049A1 - Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit - Google Patents

Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit

Info

Publication number
SG47049A1
SG47049A1 SG1996004387A SG1996004387A SG47049A1 SG 47049 A1 SG47049 A1 SG 47049A1 SG 1996004387 A SG1996004387 A SG 1996004387A SG 1996004387 A SG1996004387 A SG 1996004387A SG 47049 A1 SG47049 A1 SG 47049A1
Authority
SG
Singapore
Prior art keywords
protein
purification
reagent kit
strains
ccus
Prior art date
Application number
SG1996004387A
Other languages
English (en)
Inventor
Gunnar Lindahl
Margareth Stalhammar-Carlemalm
Lars Stenber
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Publication of SG47049A1 publication Critical patent/SG47049A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG1996004387A 1993-03-19 1994-03-21 Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit SG47049A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19

Publications (1)

Publication Number Publication Date
SG47049A1 true SG47049A1 (en) 1998-03-20

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996004387A SG47049A1 (en) 1993-03-19 1994-03-21 Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit

Country Status (18)

Country Link
US (1) US5869064A (pt)
EP (1) EP0656014B1 (pt)
JP (1) JP3976334B2 (pt)
KR (1) KR100331358B1 (pt)
CN (1) CN1046291C (pt)
AT (1) ATE240351T1 (pt)
CA (1) CA2158658A1 (pt)
DE (1) DE69432658T2 (pt)
DK (1) DK0656014T3 (pt)
ES (1) ES2194024T3 (pt)
HK (1) HK1008825A1 (pt)
HU (1) HU217582B (pt)
NZ (1) NZ263275A (pt)
PT (1) PT656014E (pt)
SG (1) SG47049A1 (pt)
SI (1) SI0656014T1 (pt)
WO (1) WO1994021685A1 (pt)
ZA (1) ZA941958B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
HU228497B1 (en) 1998-02-20 2013-03-28 Id Biomedical Corp Quebec Group b steptococcus antigens
ATE353367T1 (de) * 1998-12-22 2007-02-15 Microscience Ltd Group b streptococcus proteine und deren verwendung
HUP0201022A3 (en) * 1998-12-22 2004-07-28 Microscience Ltd Wokingham Outer surface proteins, their genes, and their use
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
HU229664B1 (en) * 1998-12-23 2014-04-28 Id Biomedical Corp Quebec Streptococcus antigens
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
DE60221126T2 (de) * 2001-05-31 2008-03-13 Fuso Pharmaceutical Industries, Ltd. Verbessertes verfahren zum nachweis und zur identifizierung eines eine infektion verursachenden mikroorganismus
WO2002101037A1 (fr) * 2001-05-31 2002-12-19 Fuso Pharmaceutical Industries, Ltd. Procede d'evaluation de la fonction de phagocytose et utilisation associee
ATE543906T1 (de) * 2002-02-11 2012-02-15 Id Biomedical Corp Antigen von streptococcus aus der b-gruppe
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions
LT2144924T (lt) 2007-04-16 2016-10-10 Minervax Aps Sulieto baltymo vakcina
CN108135992A (zh) 2015-10-21 2018-06-08 米纳瓦克斯有限责任公司 免疫原性融合蛋白
US10888610B2 (en) 2015-12-30 2021-01-12 Minerv Ax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
EP3638301A1 (en) 2017-06-16 2020-04-22 GlaxoSmithKline Biologicals S.A. Method of treatment
WO2021099982A1 (en) 2019-11-22 2021-05-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (en) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp A vaccine made from polysaccharide and protein
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
CA2103551A1 (en) * 1991-03-29 1992-09-30 Ervin Faulmann Method for production of an iga binding protein derived from group b streptococci

Also Published As

Publication number Publication date
NZ263275A (en) 1997-07-27
DE69432658D1 (de) 2003-06-18
ES2194024T3 (es) 2003-11-16
AU6389194A (en) 1994-10-11
ATE240351T1 (de) 2003-05-15
AU681130B2 (en) 1997-08-21
EP0656014B1 (en) 2003-05-14
CN1046291C (zh) 1999-11-10
HUT72841A (en) 1996-05-28
KR100331358B1 (ko) 2002-08-13
JPH09500092A (ja) 1997-01-07
HU9501993D0 (en) 1995-08-28
SI0656014T1 (en) 2003-12-31
ZA941958B (en) 1995-01-27
HU217582B (hu) 2000-02-28
KR960701096A (ko) 1996-02-24
EP0656014A1 (en) 1995-06-07
PT656014E (pt) 2003-09-30
CN1119442A (zh) 1996-03-27
CA2158658A1 (en) 1994-09-29
WO1994021685A1 (en) 1994-09-29
US5869064A (en) 1999-02-09
JP3976334B2 (ja) 2007-09-19
DE69432658T2 (de) 2004-04-08
HK1008825A1 (en) 1999-05-21
DK0656014T3 (da) 2003-08-11

Similar Documents

Publication Publication Date Title
SG47049A1 (en) Protein rib a cell surface protein that confers immunity to manu strains of the group b strepto-ccus process for purification of the protein reagent kit
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
AU1672388A (en) Expression of human proapolipoprotein a-i
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
AU1026692A (en) Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
ZA859437B (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
AU676859B2 (en) Synthetic peptides, antibodies against them and their use
WO1999015666A3 (en) Macrophage derived chemokine (mdc), mdc analogs, mdc inhibitor sustances, and uses thereof
GR3034766T3 (en) Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections.
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
CA2093427A1 (en) Molecular clones of hiv-1 and uses thereof
MX9606463A (es) Secuencias de nucleotido de las cepas pestivirus, polipeptidos codificados por estas secuencias y usos de los mismos para la diagnosis y prevencion de infecciones con pestivirus.
DE69737413D1 (en) Bakterioferritin aus helicobacter pylori
AU2529095A (en) Vaccine against mycobacterial infections
NO177570C (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
WO1996008569A3 (en) Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
HUP0104825A2 (hu) Gének, fehérjék és alkalmazásuk
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
Schmidt et al. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
NZ233672A (en) Alpha amylase-pullulanase enzyme produced by recombinant techniques and its dna coding sequence
WO2000024765A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
SE9301207D0 (sv) Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition